España
India
Italia
대한민êµ
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Akari Therapeutics
AKTX
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.9700
-0.03
-3.00%
At close: -
$0.9800
0.01
1.03%
After Hours: Dec 19, 4:25 PM EDT
Get Report
Comment
Akari Therapeutics (AKTX) Forecast
News
Earnings
Akari Therapeutics (AKTX) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Akari Therapeutics (NASDAQ:AKTX) Stock
Akari Therapeutics Stock (NASDAQ: AKTX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, December 18, 2024
Akari Therapeutics Announces Samir R. Patel, ...
Benzinga Newsdesk
Tuesday, December 17, 2024
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Monday, December 16, 2024
Akari Therapeutics Announced The Appointment ...
Benzinga Newsdesk
Tuesday, November 19, 2024
Akari Therapeutics shares are trading higher ...
Benzinga Newsdesk
Akari Therapeutics Regains Full Nasdaq Compli...
Benzinga Newsdesk
Friday, November 08, 2024
Akari Therapeutics Gains Shareholder Approval...
Benzinga Newsdesk
Monday, August 19, 2024
Akari Therapeutics Appoints Samir R. Patel As...
Benzinga Newsdesk
Akari Therapeutics Q2 EPS $0.00
Benzinga Newsdesk
Akari Therapeutics Receives FDA Feedback, Pav...
Benzinga Newsdesk
Tuesday, June 18, 2024
Akari Therapeutics 13D Filing Shows Charles S...
Benzinga Newsdesk
Tuesday, June 11, 2024
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Wednesday, June 05, 2024
Akari Therapeutics Announces Samir R. Patel,...
Benzinga Newsdesk
Tuesday, June 04, 2024
Akari Therapeutics Secures $7.6M In Upsized F...
Benzinga Newsdesk
Monday, May 27, 2024
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Friday, May 24, 2024
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Thursday, May 16, 2024
Akari Therapeutics As Of March 31, 2024, The ...
Benzinga Newsdesk
Tuesday, May 07, 2024
Akari Therapeutics Said- On May 1 Began To Implement A Reduction-in-force Of Approximately 67% Of Its Total Workforce
Charles Gross
Wednesday, May 01, 2024
Akari Therapeutics And Peak Bio Announce Port...
Benzinga Newsdesk
Akari Therapeutics Appoints Samir Patel As In...
Benzinga Newsdesk
Tuesday, April 30, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Monday, April 15, 2024
Akari Therapeutics To Present PAS-Nomacopan P...
Benzinga Newsdesk
Monday, April 01, 2024
Akari Therapeutics shares are trading lower. ...
Benzinga Newsdesk
Akari Therapeutics' Cash Of Approximately $3....
Benzinga Newsdesk
Akari Therapeutics FY2023 EPS $0.00, Same YoY
Benzinga Newsdesk
Tuesday, March 05, 2024
Akari Therapeutics And Peak Bio Announce Merg...
Benzinga Newsdesk
Tuesday, January 02, 2024
Akari Therapeutics Closes Private Placement ...
Benzinga Newsdesk
Thursday, November 16, 2023
Akari Therapeutics Presents Poster On Progres...
Benzinga Newsdesk
Monday, November 06, 2023
Akari Therapeutics To Present A Poster On Pre...
Benzinga Newsdesk
Monday, October 30, 2023
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Friday, October 13, 2023
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Friday, September 29, 2023
Akari Therapeutics H1 2023 Net Loss Of $2.99M...
Benzinga Newsdesk
Thursday, September 21, 2023
Akari Therapeutics Announces Existing Investo...
Benzinga Newsdesk
Tuesday, September 05, 2023
Akari Therapeutics Regains Compliance With Nasdaq Minimum Bid Price Requirement
Happy Mohamed
Friday, August 18, 2023
Akari Therapeutics Announces Establishment Of...
Benzinga Newsdesk
Thursday, August 17, 2023
Akari Therapeutics shares are trading lower a...
Benzinga Newsdesk
Why NICE Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
Akari Therapeutics Plc American Depositary Sh...
Happy Mohamed
Akari Therapeutics Plc American Depositary Sh...
Happy Mohamed
Akari Therapeutics Plc American Depositary Sh...
Happy Mohamed
Tuesday, August 15, 2023
Why PhenomeX Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
Akari Therapeutics shares are trading lower a...
Benzinga Newsdesk
Akari Therapeutics, Plc Announces ADS Ratio Change From 1-Representing-100 To 1-Representing-2000; Ratio Change Is Expected To Be Effective On August 17, 2023
Happy Mohamed
Monday, July 31, 2023
Why China Natural Resources Shares Are Trading Higher By Around 64%; Here Are 20 Stocks Moving Premarket
Lisa Levin
Thursday, July 27, 2023
Akari Therapeutics Granted Nomacopan Orphan Drug Designation From The European Commission For Treatment In Hematopoietic Stem Cell Transplantation
Happy Mohamed
Tuesday, July 25, 2023
Akari Therapeutics Has Been Granted EU Orphan Designation Of Nomacopan For Treatment In Hematopoietic Stem Cell Transplantation
Happy Mohamed
Thursday, July 13, 2023
Akari Therapeutics Provides Updates On Development Of Nomacopan In Pediatric And Adult HSCT-TMA
Happy Mohamed
Tuesday, July 11, 2023
Akari Therapeutics Has Selected The Version O...
Benzinga Newsdesk
Thursday, July 06, 2023
Akari Therapeutics Receives Positive Opinion ...
Benzinga Newsdesk
Friday, June 02, 2023
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Tuesday, May 16, 2023
Aspira Women's Health Names Torsten Hombeck As Chief Financial Officer Replacing Interim CFO Marlene McLennan, Effective June 15, 2023
Happy Mohamed
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch